Emletra

Emletra Tablet is used to manage and control HIV infection. It helps lower the amount of HIV in the body, supports the immune system, and reduces the risk of HIV-related complications.

Individuals should not take Emletra Tablet if they have severe liver problems, are allergic to any of its ingredients, or are taking certain medicines that can cause dangerous interactions, such as amiodarone, simvastatin, or St. John’s Wort.

Yes, Emletra Tablet may cause liver damage, especially in individuals with hepatitis B or C or pre-existing liver disease. Regular blood tests may be needed to monitor liver health during treatment.

Emletra Tablet can affect heart rhythm (PR interval prolongation) and may increase the risk of irregular heartbeat in individuals with heart disease or those taking other heart medicines. Always inform your doctor about your heart history.

Yes, Emletra Tablet has been linked to pancreatitis (inflammation of the pancreas) in some patients. Symptoms include severe stomach pain, nausea, and vomiting. Seek medical help immediately if these occur.

When starting Emletra Tablet with other HIV medicines, some patients may experience an immune system reaction called immune reconstitution inflammatory syndrome (IRIS). This can cause hidden infections to become active, leading to fever, swollen glands, or breathing problems.

Some patients on long-term HIV treatment, including Emletra Tablet, have reported osteonecrosis (bone damage). Symptoms include joint pain, stiffness, or difficulty moving. If these occur, consult your doctor.

Yes, Emletra Tablet may increase blood sugar, cholesterol, and triglyceride levels. Patients may need regular blood tests and, in some cases, treatment for diabetes or lipid disorders.

Although rare, serious allergic reactions such as swelling of the face, lips, or throat, or difficulty breathing may occur with Emletra Tablet use. Stop taking the medicine and seek emergency medical care immediately if this happens.